Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

Paroxetine Hydrochloride Anhydrous

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

75 API Suppliers, 27 USDMF, 15 CEP/COS, 9 JDMF, 12 EU WC, 13 KDMF, 13 NDC API, 26 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

29 Drugs in Development

29 Drugs in Development

INTERMEDIATES

12 Intermediate Suppliers

12 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

456 FDF Dossiers, 96 FDA Orange Book, 238 Europe, 57 Canada, 16 Australia, 23 South Africa, 26 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 10MG BASE, TABLET;ORAL - EQ 20MG BASE, TABLET;ORAL - EQ 30MG BASE, TABLET;ORAL - EQ 40MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 12.5MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 25MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 37.5MG BASE

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 2 Evonik, 1 Rochem International Inc, 6 SPI Pharma, 14 DKSH, 4 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 9 Nanjing Well Pharmaceutical, 2 Kirsch Pharma, 1 ACG Worldwide, 7 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 28 BASF, 1 Clariant, 14 Corel Pharma Chem, 6 DFE Pharma, 1 Doshion Polyscience, 1 Esteem Industries, 2 Finar, 12 Gangwal Chemicals, 9 Ideal Cures, 3 Ingredion Pharma Solutions, 23 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 12 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 6 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 26 Roquette, 14 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 3 Valens Pharmachem, 3 Vasa Pharmachem, 1 Vertellus, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

64 Fillers, Diluents & Binders, 62 Coating Systems & Additives, 33 Controlled & Modified Release, 31 Direct Compression, 30 Solubilizers, 28 Granulation, 25 Film Formers & Plasticizers, 25 Thickeners and Stabilizers, 21 Disintegrants & Superdisintegrants, 20 Topical, 20 Parenteral, 19 Taste Masking, 17 Lubricants & Glidants, 14 Co-Processed Excipients, 9 Emulsifying Agents, 9 Chewable & Orodispersible Aids, 7 Rheology Modifiers, 6 Surfactant & Foaming Agents, 6 API Stability Enhancers, 5 Empty Capsules, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 47 News #PharmaBuzz

GLOBAL SALES INFORMATION

19 US Medicaid Prescriptions, 92 Regulatory FDF Prices, 8 Annual Reports

MARKET PLACE

14 APIs, 4 FDF Dossiers

PATENTS & EXCLUSIVITIES

55 Health Canada Patents

55 Health Canada Patents

REF. STANDARDS & IMPURITIES

8 EDQM, 1 USP, 4 JP, 15 Others

ANALYTICAL

4 BioAnalytical Methods, 1 Analytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
29/11/2025	Aesica Pharmaceuticals Limited	United Kingdom	AESICA PHARMACEUTICALS LIMITED Cramlington GB	R1-CEP 2006-096 - Rev 00	Paroxetine hydrochloride	2012-10-11	Withdrawn by Holder	Chemical	2023-05-15	2283
29/11/2025	Aesica Pharmaceuticals Limited	United Kingdom	AESICA PHARMACEUTICALS LIMITED Cramlington GB	R1-CEP 2006-081 - Rev 00	Paroxetine hydrochloride hemihydrate	2012-10-17	Withdrawn by Holder	Chemical	2023-05-17	2018

Paroxetine Hydrochloride Anhydrous

Paroxetine Hydrochloride Anhydrous

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

75 API Suppliers

27 USDMF

15 CEP/COS

9 JDMF

12 EU WC

13 KDMF

13 NDC API

26 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

29 Drugs in Development

INTERMEDIATES

12 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

456 FDF Dossiers

96 FDA Orange Book

238 Europe

57 Canada

16 Australia

23 South Africa

26 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 10MG BASE

TABLET;ORAL - EQ 20MG BASE

TABLET;ORAL - EQ 30MG BASE

TABLET;ORAL - EQ 40MG BASE

TABLET, EXTENDED RELEASE;ORAL - EQ 12.5MG BASE

TABLET, EXTENDED RELEASE;ORAL - EQ 25MG BASE

TABLET, EXTENDED RELEASE;ORAL - EQ 37.5MG BASE

RELATED EXCIPIENT COMPANIES

2 EUROAPI

2 Evonik

1 Rochem International Inc

6 SPI Pharma

14 DKSH

4 Boai NKY Pharmaceuticals Ltd

5 Gangwal Healthcare

9 Nanjing Well Pharmaceutical

2 Kirsch Pharma

1 ACG Worldwide

7 Actylis

1 Aeon Procare

1 Alcedo Pharmachem

6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

28 BASF

1 Clariant

14 Corel Pharma Chem

6 DFE Pharma

1 Doshion Polyscience

1 Esteem Industries

2 Finar

12 Gangwal Chemicals

9 Ideal Cures

3 Ingredion Pharma Solutions

23 Kerry

2 Keval Exports

3 Kima Chemical

6 Lonza Capsugel

12 Microlex e.U

1 Nanjing Bold Chemical

2 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

2 Novo Excipients

3 Pharmatrans-Sanaq

6 Pluviaendo

3 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

26 Roquette

14 Seppic

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd